Clinical trial
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
NCT02597049
Study timeline
Study start (unknown)2015-11-01Date precision: month
Registry last updated2020-06-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
DulaglutideDRUG · verified · RxNorm: dulaglutide
PlaceboDRUG
SGLT2 inhibitorDRUG
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02597049 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.